Pursuant to Regulations 30 and 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we submit herewith the Unaudited Financial Results of the Company for ....
RESULTS
▲ Positive Development
LOW RISK
📅 Filed on BSE: 28 Jul 2026, 01:52 PM IST · BSE ID: 0ead03d4-4842-46fc-a8cd-79d8f4672acf
View Original BSE Filing (PDF)
💡
In Simple Terms
Pfizer Ltd reported its quarterly financial results, showing Rs. 653.17 crore in sales and Rs. 204.47 crore in profit.
🤖 AI Summary
- Pfizer Ltd reported unaudited net profit of Rs. 204.47 crore for the quarter ended June 30, 2026.
- Revenue from operations for the same quarter was Rs. 653.17 crore, increasing from Rs. 603.05 crore YoY.
- Basic and Diluted Earnings Per Share (EPS) for the quarter stood at Rs. 44.69.
- Total income for the quarter ended June 30, 2026, reached Rs. 698.01 crore.
- The Board of Directors approved the Q1 FY27 financial results on July 28, 2026.
🔢 Key Numbers — exact figures from BSE filing, not rounded
Revenue from operations (3 months ended 30/06/2026)
653.17 Rs. crore
8.31%
Net profit for the period (3 months ended 30/06/2026)
204.47 Rs. crore
6.63%
Earnings per share -Basic and Diluted (3 months ended 30/06/2026)
44.69 Rs.
6.63%
Total income (3 months ended 30/06/2026)
698.01 Rs. crore
4.15%
🏢 How This Affects the Company
Revenue from operations increased to Rs. 653.17 crore in Q1 FY27 compared to Rs. 603.05 crore in the corresponding prior year quarter. This indicates a growth in the company's core pharmaceutical business activities.
Net profit for the period rose to Rs. 204.47 crore from Rs. 191.75 crore in the prior corresponding quarter. Total comprehensive income for the period also increased to Rs. 203.93 crore.
👥 What This Means For Shareholders
✅
Action Required
No immediate action is required by shareholders based on this financial results filing.
👤
Who Is Affected
All shareholders of Pfizer Ltd are affected by the company's financial performance, specifically the net profit of Rs. 204.47 crore and EPS of Rs. 44.69 for the quarter.
🔍
Management Signal
The approval and disclosure of the unaudited financial results signal management's adherence to regulatory compliance and transparent reporting of operational performance.
For information only. Not investment advice. ForgeUp is not SEBI-registered.
👁 Watch List — track these upcoming events
Q2 FY27 financial results — check for continued revenue and profit growth.
Updates on the impact of New Labour Codes on employee benefits expenses.
Further details on the Supply and Marketing Agreement with Cipla Limited.
LOW RISK
The filing indicates a stable financial performance with no new significant risks identified.
💡 Investor Takeaway
Pfizer Ltd reported Q1 FY27 unaudited financial results with revenue from operations at Rs. 653.17 crore, a 8.31% increase from Rs. 603.05 crore in Q1 FY26. Net profit rose to Rs. 204.47 crore, up 6.63% from Rs. 191.75 crore YoY, confirming an upward trend.
⚖️ Strengths & Concerns
✅ Positives
- Revenue from operations increased to Rs. 653.17 crore in Q1 FY27, up from Rs. 603.05 crore in Q1 FY26.
- Net profit for the period grew to Rs. 204.47 crore in Q1 FY27, compared to Rs. 191.75 crore in Q1 FY26.
⚠️ Concerns
- Other income decreased to Rs. 44.84 crore in Q1 FY27 from Rs. 67.17 crore in the corresponding prior year quarter.
- Employee benefits expense slightly decreased to Rs. 82.08 crore in Q1 FY27 from Rs. 95.82 crore in Q1 FY26.
📅 Company Track Record
A previous filing on May 12, 2026, indicated that Pfizer Ltd's Board approved FY26 results and recommended a final dividend of Rs. 75/- per share. The current filing provides an update on the Q1 FY27 performance.
Based on publicly available historical data. For context only.
❓ Frequently Asked Questions
What was Pfizer Ltd's net profit for the quarter ended June 30, 2026?
Pfizer Ltd reported a net profit of Rs. 204.47 crore for the quarter ended June 30, 2026.
What was Pfizer Ltd's revenue from operations for Q1 FY27?
Revenue from operations for Pfizer Ltd for the quarter ended June 30, 2026, was Rs. 653.17 crore.
How much did Pfizer Ltd's earnings per share (Basic and Diluted) stand at for Q1 FY27?
Pfizer Ltd's Basic and Diluted Earnings Per Share (EPS) for the quarter ended June 30, 2026, was Rs. 44.69.
What was the total income for Pfizer Ltd in the quarter ended June 30, 2026?
The total income for Pfizer Ltd for the quarter ended June 30, 2026, was Rs. 698.01 crore.
Questions based on this BSE filing only. For information purposes.